The cytoskeletal changes that alter cellular morphogenesis and motility depend upon a complex interplay among molecules that regulate actin, myosin, and other cytoskeletal components. The Rho family of GTP binding proteins are important upstream mediators of cytoskeletal organization. Gem and Rad are members of another family of small GTP binding proteins (the Rad, Gem, and Kir family) for which biochemical functions have been mostly unknown. Here we show that Gem and Rad interface with the Rho pathway through association with the Rho effectors, Rho kinase (ROK) α and β. Gem binds ROKβ independently of RhoA in the ROKβ coiled-coil region adjacent to the Rho binding domain. Expression of Gem inhibited ROKβ-mediated phosphorylation of myosin light chain and myosin phosphatase, but not LIM kinase, suggesting that Gem acts by modifying the substrate specificity of ROKβ. Gem or Rad expression led to cell flattening and neurite extension in N1E-115 neuroblastoma cells. In interference assays, Gem opposed ROKβ- and Rad opposed ROKα-mediated cell rounding and neurite retraction. Gem did not oppose cell rounding initiated by ROKβ containing a deletion of the Gem binding region, demonstrating that Gem binding to ROKβ is required for the effects observed. In epithelial or fibroblastic cells, Gem or Rad expression resulted in stress fiber and focal adhesion disassembly. In addition, Gem reverted the anchorage-independent growth and invasiveness of Dbl-transformed fibroblasts. These results identify physiological roles for Gem and Rad in cytoskeletal regulation mediated by ROK.
Skip Nav Destination
Article navigation
15 April 2002
Article|
April 15 2002
The GTP binding proteins Gem and Rad are negative regulators of the Rho–Rho kinase pathway
Yvona Ward,
Yvona Ward
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Search for other works by this author on:
Seow-Fong Yap,
Seow-Fong Yap
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Search for other works by this author on:
V. Ravichandran,
V. Ravichandran
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Search for other works by this author on:
Fumio Matsumura,
Fumio Matsumura
2Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08855
Search for other works by this author on:
Masaaki Ito,
Masaaki Ito
3First Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507 Japan
Search for other works by this author on:
Beth Spinelli,
Beth Spinelli
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Search for other works by this author on:
Kathleen Kelly
Kathleen Kelly
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Search for other works by this author on:
Yvona Ward
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Seow-Fong Yap
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
V. Ravichandran
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Fumio Matsumura
2Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08855
Masaaki Ito
3First Department of Internal Medicine, Mie University School of Medicine, Mie 514-8507 Japan
Beth Spinelli
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Kathleen Kelly
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892
Address correspondence to Kathleen Kelly, Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Building 10, Room 3B43, Bethesda, MD 20892. Tel.: (301) 435-4651. Fax: (301) 435-4655. E-mail: [email protected]
*
Abbreviations used in this paper: aa, amino acid(s); GFP, green fluorescence protein; GST, glutathione-S-transferase; HA, hemagglutinin; LIMK, LIM kinase; MBS, myosin binding subunit; MLC, regulatory myosin light chain; PBD, p21 Rho binding domain; RGK, Rad, Gem, and Kir; ROKβ or ROKα, Rho kinase β or α; SC, synthetic complete.
Received:
November 08 2001
Revision Received:
March 11 2002
Accepted:
March 12 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2002
J Cell Biol (2002) 157 (2): 291–302.
Article history
Received:
November 08 2001
Revision Received:
March 11 2002
Accepted:
March 12 2002
Citation
Yvona Ward, Seow-Fong Yap, V. Ravichandran, Fumio Matsumura, Masaaki Ito, Beth Spinelli, Kathleen Kelly; The GTP binding proteins Gem and Rad are negative regulators of the Rho–Rho kinase pathway . J Cell Biol 15 April 2002; 157 (2): 291–302. doi: https://doi.org/10.1083/jcb.200111026
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement